$1.7 Million Settlement – Medical Malpractice

Seeger Weiss Obtains $1.7 Million Recovery for Physician’s Failure to Diagnose Renal Disease in Timely Manner In a medical malpractice case pending in Supreme Court, Bronx County, Seeger Weiss came to a $1.7 million settlement agreement earlier this month on behalf of a client who has been diagnosed with end stage renal disease. The case, […]

August 9, 2010

Medical Malpractice

Seeger Weiss Obtains $1.7 Million Recovery for Physician’s Failure to Diagnose Renal Disease in Timely Manner

In a medical malpractice case pending in Supreme Court, Bronx County, Seeger Weiss came to a $1.7 million settlement agreement earlier this month on behalf of a client who has been diagnosed with end stage renal disease.

The case, brought against our client’s primary care physician, alleged that the physician’s failed to recognize signs and symptoms of kidney dysfunction over a period of nearly two years. In addition, this failure to diagnose and treat the client’s condition in its early stages was a significant factor in our client’s current diagnosis of advanced renal disease.

“This case underscores the importance of closely monitoring even routine blood test results,” said Seeger Weiss partner Marc S. Albert. “Simply put, this client’s kidney disease should have been diagnosed much earlier than it ultimately was. Unfortunately, blood tests over nearly a two year period, which showed elevated and continuously rising Creatinine and BUN levels—clear indications of renal disease—were not being carefully reviewed by his physician.”

During the course of the case, our client appeared on a CBS News special highlighting a problem that has become somewhat endemic in the medical field: physicians’ cavalier approach to reviewing patient’s test results. CBS, in a recent news story, reported on a number of patients—including our client—who had serious medical conditions slip through the cracks when test results were not carefully evaluated by their physician.

“We are extremely satisfied with what we feel is a just result for our client in this case,” said Mr. Albert.

Notwithstanding claims relating to this product, the drug/medical device remains approved by the U.S. FDA.

Related News

November 19, 2025
Shauna Itri Appointed to Sedona Conference Working Group 1 (WG1) Steering Committee

Seeger Weiss is proud to announce that Partner Shauna Itri has been appointed to the Sedona Conference Working Group 1 (WG1) Steering Committee for a three-year term beginning January 1, 2026. This appointment reflects Shauna’s longstanding leadership and dedication to advancing best practices in eDiscovery and information governance. Shauna has played a pivotal role in […]

Read More
November 7, 2025
Seeger Weiss Recognized Nationally and Regionally in the 16th Edition of Best Law Firms® in the United States

Seeger Weiss received national and regional rankings in the 16th edition of Best Law Firms® in the United States. The recognition highlights the firm’s work in mass tort, product liability, personal injury, medical malpractice, and commercial litigation, personal injury, medical malpractice, and commercial litigation. The Best Law Firms® rankings are a trusted standard in the […]

Read More
November 4, 2025
Founding Partner Christopher Seeger Wins Lifetime Achievement Award and Firm Wins Class Action Litigation Department of the Year

Seeger Weiss is proud to announce two honors at the 2025 New Jersey Legal Awards hosted by the New Jersey Law Journal. Founding partner Christopher Seeger received the Lifetime Achievement Award, and the firm won Litigation Department of the Year Award in the Class Action category. Partner Jennifer Scullion was selected as a finalist for […]

Read More